[Patient with breast cancer and bilateral serous retinal detachment].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A Thölen.
Explore the source record for details and available documents.
BACKGROUND: The "white dot syndromes" are a clinically heterogeneous group of inflammatory chorioretinopathies with an inconsistent classification. It is not yet clear if they represent distinct entities or if they are only different forms of the same basic disease. CASE REPORT: A 53-year-old female patient presented with unilateral photopsia and reduced vision in the left eye. Funduscopy of the left eye showed peripapillary confluent whitish infiltrates in the deep retinal layers with corresponding enlargement of the blind spot. Slow progression of the lesions was observed followed by the development of subretinal fibrosis in the macula. The ERG was reduced in the left eye. In both eyes there were small round, partly confluent areas of RPE atrophy in the lower fundus periphery without inflammatory reaction in the vitreous body or anterior chamber. CONCLUSION: The presented case shows overlapping features of acute zonal occult outer retinopathy (AZOOR), multifocal choroiditis and diffuse subretinal fibrosis and uveitis. This case and other previously described cases with overlaps between different clinical entities support the theory that clinically different inflammatory chorioretinal diseases may represent parts of a spectrum of one common disease.
BACKGROUND: TINU-Syndrome (Acute tubulointerstitial nephritis and uveitis) is a rare immune-mediated disease, primarily occurring in children and young women. Uveitis may precede, follow or occur concomitantly with nephritis. Corticosteroids are the mainstay of therapy. PATIENT: A 73-year old female patient with tubulointerstitial nephritis and recurrences of anterior uveitis was diagnosed having TINU syndrome. During follow-up she developed bilateral cystoid macular edema with accompanying visual loss. Nephritis and uveitis responded well to oral corticosteroids. CONCLUSIONS: Uveitis screening should exclude renal disease independent of the age of the patient. Diagnosis can often be inferred from anamnesis, physical examination, or laboratory tests. Renal biopsy as the most definite method of diagnosis may be necessary. Ophthalmologic follow-up on a regular basis is mandatory for a successful management of long-term complications.
BACKGROUND: Because of its considerable differential diagnosis and a wide range of phenotypic variation, Stargardt's disease (juvenile macular dystrophy) can cause diagnostic problems. Moreover, ample variability in course and outcome of the disease has been described. PATIENTS AND METHODS: The diagnosis and variable course of Stargardt's disease of three affected siblings have been documented by clinical manifestation, fluorescein angiography and Ganzfeld-ERG including the ISCEV standard protocol. RESULTS: All three siblings presented with retinal abnormalities. However, only the youngest brother revealed symptoms for more than 10 y in terms of reduced visual acuity. The two elder ones had preserved central vision. Classical findings of contact lens biomicroscopy, fluorescein angiography and changes in the Ganzfeld-ERG confirmed the diagnosis of Stargardt's disease. CONCLUSIONS: The diagnosis of Stargardt's disease can be made as late as in the 7th decade of life. Tremendous variability can occur in course and outcome even within the same family. Therefore, visual prognosis is uncertain and has to be made with caution. In most cases the diagnosis can be established with the above mentioned methods.
BACKGROUND: The purpose of this study was to measure the activity of the sympathetic nervous system in patients with central serous chorioretinopathy (CSC) by power spectral analysis (PSA) of heart-rate (RR-interval) variability, a noninvasive method that reflects the balance of the sympathetic-vagal interaction. METHODS: The following four different groups of patients were measured; group 1, acute CSC (n = 11); group 2, acute recurrent CSC (n = 7); group 3, chronic persistent CSC (n = 4); group 4, complete remission of CSC (n = 9). The data recorded for these 31 patients (29 men and 2 women), with an average age of 44 years were compared with those noted for a group of 15 age-matched healthy individuals. The sympathetic-vagal balance is expressed by the ratio of the low-frequency component (LF) to the high-frequency component (HF) of the power spectrum. RESULTS: Significant differences in mean LF/HF ratios were found as follows for all but one of the sub-groups as compared with the normal controls (LF/HF = 1.1): group 1, LF/HF = 5.5 (P < 0.01); group 2, LF/HF = 5.4 (P < 0.05); group 3, LF/HF = 4.2 (P = 0.1); and group 4, LF/HF = 3.0 (P < 0.01). There was also a significant difference between active CSC and inactive CSC (P < 0.05). CONCLUSIONS: These results support the view that the pathogenesis of CSC is related to an increase in the sympathetic activity of the autonomic nervous system. Furthermore, the LF/HF ratios seem to correlate with the activity of the disease.
Laser treatment of subfoveal neovascular membranes secondary to age-related macular degeneration (AMD) has been proven to be beneficial with regard to long-term contrast sensitivity and central scotoma size, but significant visual loss occurs immediately after treatment and it is therefore not generally accepted. Alternative treatment modalities should be evaluated. The observation made by Dr. W. Fung that patients with subretinal neovascular membranes may benefit from systemic treatment with the angiogenesis inhibitor interferon alpha-2a has stimulated much interest in this new treatment modality. We present four patients suffering from a subfoveal neovascular membrane who have been treated with this drug. In three cases the membrane was of an occult type, in one case there was a combination of classic and occult choroidal neovascularization. In all patients there had been progressive visual loss during the last 6 months prior to treatment. Visual acuity stabilized in three cases with occult neovascularization. In one case with classic choroidal neovascularization the membrane increased in size during treatment and a further drop of visual acuity was noted. Despite the fact that serious side effects could not be observed in our patients, the results do not allow to recommend Interferon for widespread use in the treatment of subretinal neovascular membranes, especially because the number of patients was small and the follow up time short. Its efficacy needs to be demonstrated by randomized clinical trials.
Since eye pairs are anatomically and pathologically asymmetrical, we attempted to determine whether the transition from ocular hypertension to glaucoma might be typified by lateral differences in either intraocular pressure (IOP), papillary excavation, or visual field. Such lateral differences were sought in a retrospective study of the medical records of 47 patients exhibiting ocular hypertension, of whom 25 remained hypertensives and 22 developed glaucoma during the period considered. Although all visual field indices in the latter group had remained within the normal range, the same side consistently yielded significantly worse results in mean sensitivity, and the absolute value for the lateral difference in these individuals was significantly higher than that found for the patients who did not develop glaucoma. Future glaucoma is manifested when the mean sensitivity remains worse in one eye.